![Michelle Morrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Morrow
Keine laufenden Positionen mehr
Profil
Michelle Morrow worked as Chief Scientific Officer at Avacta Group Plc from 2024 to 2026.
Dr. Morrow also worked as Senior VP & Head-Therapeutics Innovation at invoX Pharma Ltd. Dr. Morrow earned a doctorate from the University of Cambridge.
Ehemalige bekannte Positionen von Michelle Morrow
| Unternehmen | Position | Ende |
|---|---|---|
| AVACTA GROUP PLC | Technik-/Wissenschafts-/F&E-Leiter | 09.02.2026 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | - |
Ausbildung von Michelle Morrow
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
